Validation and comparison of quality-of-life measures for topical 5-fluorouracil treatment: results from a randomized controlled trial
H. Pomerantz, M. M. Chren, R. Lew, M. A. Weinstock, S. C. Chen, R. P. Dellavalle, E. M. Warshaw, J. J. DiGiovanna, R. Ferguson, R. Ringer, J. Yoon, C. S. Phibbs, K. Kraemer, D. Hogan, D. Eilers, S. Swetter, S. C. Chen, S. Jacob, E. M. Warshaw, G. StricklinN. Konnikov, V. Werth, N. Sidhu-Malik, J. Keri, J. W. Swan, K. Nord, B. Pollack, S. Kempiak, W. High, N. Fett, Rl P. Hall, J. R. Alonso-Llamazares, G. Rodriguez, L. Sisler, M. O'Sullivan, S. Wilson, M. Agrawal, D. Bartenfeld, K. Nicalo, D. Johnson, P. Parks, B. Bidek, N. Boyd, B. Watson, D. Wolfe, M. Zacheis, J. Okawa, M. A. Iannacchione, J. Quintero, A. Bershow, the VA Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group*
Dive into the research topics of 'Validation and comparison of quality-of-life measures for topical 5-fluorouracil treatment: results from a randomized controlled trial'. Together they form a unique fingerprint.